Cov khoom lag luam
Lus Askiv Lub Npe: Alemtuzumab
Tus lej lej: 216503-57-0
Molecular Cov Qauv
Molecular hnyav: 0
Einecs tsis muaj
Lwm yam ntawm cov tshuaj
Cov Mol Cov Ntaub Ntawv: MOL cov ntaub ntawv
Cov Qauv Txheej Txheem:
Tag nrho cov khoom ntiag tug
Daim Ntawv: Ua Kua
Xim: tsis muaj xim daj rau daj daj
Alenzumab siv thiab cov qauv hluavtaws
Cov lus qhia luv luv
Luam lag luam ntawm Aronzumab (Alemtuzumab): Ligtrad, pom zoo tau pom zoo hauv Tebchaws Meskas: Ligtrad, pom zoo hauv Tebchaws Meskas hauv xyoo 2001.
Mechanism ntawm Kev Ua
Alemtuzumab yog tib neeg monoclonal antibody hom phiaj CD52 uas khi rau CD52 nyob rau ntawm t lymphocytes thiab b (ADCC).
Phiaj Xwm
Cd52
Kev siv
Alemtuzumab yog siv los kho cov mob qog noj mov hauv xov tooj hauv tes B-Cell Cell
Cov Ntaub Ntawv Seev Cev
Cov ntaub ntawv lom neeg cov ntaub ntawv: {216503-57-0 (cov ntaub ntawv muaj kev phom sij)
Cim npe nrov: Alemtuzumab Monoclonal Antibody rau cov kab mob leukemia, Tuam Tshoj Alemtuzumab Monoclonal Antibody rau Cov QUUKEMIA
